Table 2.
Baseline clinical characteristics in intracerebral hemorrhage patients with good and poor functional outcome
|
Good outcome (n = 102) |
Poor outcome (n = 48) |
p value | |
|---|---|---|---|
| Age (years), median (q1, q3) | 59 ± 11 | 65 ± 13 | .009 |
| Female sex, n (%) | 30 (29.4) | 21 (43.8) | .084 |
| Risk factors, n (%) | |||
| Hypertension | 71 (69.6) | 37 (77.1) | .342 |
| Hyperlipidemia | 11 (10.8) | 11 (22.9) | .050 |
| CAD | 2 (2.0) | 2 (4.2) | .434 |
| History of stroke | 11 (10.8) | 6 (12.5) | .757 |
| Current smoking | 43 (42.2) | 14 (29.2) | .126 |
| Current drinking | 40 (39.2) | 19 (39.6) | .966 |
| Lesion location, n (%) | .970 | ||
| Brain lobe | 9 (8.8) | 3 (6.3) | |
| Basal ganglia | 43 (42.2) | 25 (52.1) | |
| Thalamus | 19 (18.6) | 6 (12.5) | |
| Brainstem | 11 (10.8) | 4 (8.3) | |
| Cerebellum | 11 (10.8) | 3 (6.3) | |
| Other | 9 (8.8) | 7 (14.5) | |
|
Lesion area (ml) median (q1, q3) |
|||
| Hematoma volume | 4.27 (1.47–8.29) | 14.72 (6.99–23.33) | <.001 |
| Edema volume | 5.60 (1.77–11.88) | 20.63 (7.34–36.18) | <.001 |
| Hematoma enlargement | 28 (27.5) | 21 (43.8) | .047 |
| Edema extension distance | 0.79 (0.06–1.73) | 0.77 (0.39–1.50) | .672 |
| Time from stroke onset to admission (hr) | 9.5 (3–24) | 7.5 (3–24) | .727 |
| NIHSS | 3（1–5） | 10 (6–13) | <.001 |
| Glycemic status | <.001 | ||
| Non‐DM | 46 (45.1) | 5 (10.4) | |
| PreDM | 36 (35.3) | 22 (45.8) | |
| DM | 20 (19.6) | 21 (43.8) |
Values are shown as number (percentage) or as median (quartiles).
Abbreviation: CAD, coronary artery disease; DM, diabetes mellitus; IQR, interquartile range; PreDM, prediabetes; NIHSS, National Institutes of Health Stroke Scale.